These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38796751)

  • 1. Cholecystitis following the initiation of glucagon-like peptide-2 analogue for short bowel syndrome: A case report.
    Goto Y; Masumoto K; Jimbo T; Sasaki T; Tanaka Y; Shirane K
    Nutr Clin Pract; 2024 May; ():. PubMed ID: 38796751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.
    Jeppesen PB; Sanguinetti EL; Buchman A; Howard L; Scolapio JS; Ziegler TR; Gregory J; Tappenden KA; Holst J; Mortensen PB
    Gut; 2005 Sep; 54(9):1224-31. PubMed ID: 16099790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K; Schwartz L; Batisti J; Iyer KR
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
    Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teduglutide: a review of its use in the treatment of patients with short bowel syndrome.
    Burness CB; McCormack PL
    Drugs; 2013 Jun; 73(9):935-47. PubMed ID: 23729002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teduglutide-Stimulated Intestinal Adaptation Is Complemented and Synergistically Enhanced by Partial Enteral Nutrition in a Neonatal Piglet Model of Short Bowel Syndrome.
    Naberhuis JK; Deutsch AS; Tappenden KA
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):853-865. PubMed ID: 26304601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making.
    Sowerbutts AM; Burden S; Griffiths J; Abraham A; Farrer K; Leahy G; Teubner A; Cloutier A; Twist K; Kelly S; Lal S
    Clin Nutr ESPEN; 2021 Aug; 44():263-269. PubMed ID: 34330477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome.
    Lambe C; Talbotec C; Kapel N; Barbot-Trystram L; Brabant S; Nader EA; Pigneur B; Payen E; Goulet O
    Am J Clin Nutr; 2023 Jun; 117(6):1152-1163. PubMed ID: 37270289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging treatment options for short bowel syndrome: potential role of teduglutide.
    Tee CT; Wallis K; Gabe SM
    Clin Exp Gastroenterol; 2011; 4():189-96. PubMed ID: 22016579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Teduglutide in Children With Intestinal Failure: A Systematic Review.
    Gigola F; Cianci MC; Cirocchi R; Ranucci MC; Del Riccio M; Coletta R; Morabito A
    Front Nutr; 2022; 9():866518. PubMed ID: 35774551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 14. Examining the pathophysiology of short bowel syndrome and glucagon-like peptide 2 analogue suitability in chronic intestinal failure: experience from a national intestinal failure unit.
    Bond A; Taylor M; Abraham A; Teubner A; Soop M; Carlson G; Lal S
    Eur J Clin Nutr; 2019 May; 73(5):751-756. PubMed ID: 30111847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
    Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G610-22. PubMed ID: 22744334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teduglutide for the treatment of short bowel syndrome.
    Jeppesen PB
    Drugs Today (Barc); 2013 Oct; 49(10):599-614. PubMed ID: 24191254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging intestinal failure with Teduglutide - A case report.
    Schlager L; Stift A; Gartner J; Hütterer E; Harpain F
    Int J Surg Case Rep; 2021 Sep; 86():106270. PubMed ID: 34418803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
    Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome.
    Koopmann MC; Liu X; Boehler CJ; Murali SG; Holst JJ; Ney DM
    JPEN J Parenter Enteral Nutr; 2009; 33(6):629-38; discussion 638-9. PubMed ID: 19644131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.